Sign in or create an account to add this stock to your watchlist.
About 1-800-PetMeds (NASDAQ:PETS)
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies through its Website. It markets its products through Internet; telephone contact center; and direct mail/print through 1-800-PetMeds catalogs, brochures, and postcards under various brands. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444
Debt
Debt-to-Equity RatioN/A
Current Ratio5.81
Quick Ratio4.52
Price-To-Earnings
Trailing P/E Ratio20.22
Forward P/E Ratio16.14
P/E Growth1.57
Sales & Book Value
Annual Sales$273.80 million
Price / Sales2.77
Cash Flow$1.9637 per share
Price / Cash18.74
Book Value$5.62 per share
Price / Book6.55
Profitability
EPS (Most Recent Fiscal Year)$1.82
Net Income$37.28 million
Net Margins13.62%
Return on Equity34.76%
Return on Assets28.63%
Miscellaneous
Employees187
Outstanding Shares20,600,000
1-800-PetMeds (NASDAQ:PETS) Frequently Asked Questions
What is 1-800-PetMeds' stock symbol?
1-800-PetMeds trades on the NASDAQ under the ticker symbol "PETS."
How often does 1-800-PetMeds pay dividends? What is the dividend yield for 1-800-PetMeds?
1-800-PetMeds announced a quarterly dividend on Monday, May 7th. Stockholders of record on Friday, May 18th will be paid a dividend of $0.25 per share on Friday, May 25th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.72%. The ex-dividend date of this dividend is Thursday, May 17th. View 1-800-PetMeds' Dividend History.
How were 1-800-PetMeds' earnings last quarter?
1-800-PetMeds (NASDAQ:PETS) issued its earnings results on Monday, May, 7th. The company reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.03. The company had revenue of $67.30 million for the quarter, compared to analyst estimates of $68.43 million. 1-800-PetMeds had a net margin of 13.62% and a return on equity of 34.76%. The business's quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.37 earnings per share. View 1-800-PetMeds' Earnings History.
When is 1-800-PetMeds' next earnings date?
What price target have analysts set for PETS?
5 equities research analysts have issued 1 year target prices for 1-800-PetMeds' stock. Their predictions range from $19.00 to $58.00. On average, they anticipate 1-800-PetMeds' stock price to reach $40.50 in the next year. View Analyst Ratings for 1-800-PetMeds.
Who are some of 1-800-PetMeds' key competitors?
Who are 1-800-PetMeds' key executives?
1-800-PetMeds' management team includes the folowing people:
- Mr. Menderes Akdag, Chief Exec. Officer, Pres & Director (Age 57)
- Mr. Bruce S. Rosenbloom, CFO, Principal Accounting Officer & Treasurer (Age 49)
- Ms. Alison Berges, Corp. Sec. & Gen. Counsel
Has 1-800-PetMeds been receiving favorable news coverage?
Headlines about PETS stock have trended somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. 1-800-PetMeds earned a coverage optimism score of 0.13 on Accern's scale. They also gave news headlines about the company an impact score of 46.69 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of 1-800-PetMeds?
Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is 1-800-PetMeds' stock price today?
One share of PETS stock can currently be purchased for approximately $36.80.
How big of a company is 1-800-PetMeds?
1-800-PetMeds has a market capitalization of $738.55 million and generates $273.80 million in revenue each year. The company earns $37.28 million in net income (profit) each year or $1.82 on an earnings per share basis. 1-800-PetMeds employs 187 workers across the globe.
How can I contact 1-800-PetMeds?
1-800-PetMeds' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.
MarketBeat Community Rating for 1-800-PetMeds (PETS)
MarketBeat's community ratings are surveys of what our community members think about 1-800-PetMeds and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
1-800-PetMeds (NASDAQ:PETS) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for 1-800-PetMeds in the last 12 months. Their average twelve-month price target is $40.50, suggesting that the stock has a possible upside of 10.05%. The high price target for PETS is $58.00 and the low price target for PETS is $19.00. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.20 | 2.20 | 2.20 | 2.20 |
| Ratings Breakdown: | 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $40.50 | $41.00 | $41.00 | $40.00 |
| Price Target Upside: | 10.05% upside | 12.77% downside | 12.77% downside | 14.55% upside |
1-800-PetMeds (NASDAQ:PETS) Consensus Price Target History
1-800-PetMeds (NASDAQ:PETS) Analyst Ratings History
Show:
(Data available from 5/22/2016 forward)
1-800-PetMeds (NASDAQ:PETS) Dividend Information
1-800-PetMeds pays an annual dividend of $1.00 per share, with a dividend yield of 2.72%. PETS's next quarterly dividend payment will be made on Friday, May 25. 1-800-PetMeds pays out 54.95% of its earnings out as a dividend.
| Next Dividend: | 5/25/2018 |
| Annual Dividend: | $1.00 |
| Dividend Yield: | 2.72% |
| Payout Ratio(s): | 54.95% (Trailing 12 Months of Earnings)
43.86% (Based on This Year's Estimates)
37.59% (Based on Next Year's Estimates)
50.92% (Based on Cash Flow)
|
1-800-PetMeds (NASDAQ:PETS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 5/7/2018 | quarterly | $0.25 | 2.92% | 5/17/2018 | 5/18/2018 | 5/25/2018 |
| 1/22/2018 | quarterly | $0.25 | 2.4% | 2/2/2018 | 2/5/2018 | 2/16/2018 |
| 10/24/2017 | quarterly | $0.20 | 2.08% | 11/3/2017 | 11/6/2017 | 11/17/2017 |
| 7/24/2017 | quarterly | $0.20 | 1.66% | 8/3/2017 | 8/7/2017 | 8/18/2017 |
| 5/8/2017 | quarterly | $0.20 | | 5/17/2017 | 5/19/2017 | 5/26/2017 |
| 1/23/2017 | quarterly | $0.19 | 3.61% | 2/2/2017 | 2/6/2017 | 2/17/2017 |
| 10/24/2016 | quarterly | $0.19 | 3.84% | 11/3/2016 | 11/7/2016 | 11/18/2016 |
| 7/25/2016 | quarterly | $0.19 | 3.71% | 8/4/2016 | 8/8/2016 | 8/19/2016 |
| 5/9/2016 | quarterly | $0.19 | 3.9% | 5/18/2016 | 5/20/2016 | 5/27/2016 |
| 1/25/2016 | quarterly | $0.18 | 4.04% | 2/4/2016 | 2/8/2016 | 2/19/2016 |
| 10/19/2015 | quarterly | $0.18 | 4.28% | 10/29/2015 | 11/2/2015 | 11/13/2015 |
| 7/20/2015 | quarterly | $0.18 | 4.23% | 7/30/2015 | 8/3/2015 | 8/14/2015 |
| 5/4/2015 | quarterly | $0.18 | 4.41% | 5/13/2015 | 5/15/2015 | 5/22/2015 |
| 1/20/2015 | quarterly | $0.17 | 4.2% | 1/30/2015 | 2/3/2015 | 2/13/2015 |
| 10/20/2014 | quarterly | $0.17 | | 10/30/2014 | 11/3/2014 | 11/14/2014 |
| 7/21/2014 | quarterly | $0.17 | 4.79% | 7/31/2014 | 8/4/2014 | 8/15/2014 |
| 5/5/2014 | quarterly | $0.17 | 5.22% | 5/14/2014 | 5/16/2014 | 5/23/2014 |
| 1/30/2014 | quarterly | $0.17 | 5.14% | 2/10/2014 | 2/12/2014 | 2/21/2014 |
| 10/28/2013 | quarterly | $0.17 | 4.56% | 11/6/2013 | 11/8/2013 | 11/22/2013 |
| 7/26/2013 | quarterly | $0.17 | 4.16% | 8/8/2013 | 8/12/2013 | 8/23/2013 |
| 5/3/2013 | quarterly | $0.15 | 4.65% | 5/13/2013 | 5/15/2013 | 5/24/2013 |
| 1/28/2013 | quarterly | $0.15 | 4.64% | 2/6/2013 | 2/8/2013 | 2/22/2013 |
(Data available from 1/1/2013 forward)
1-800-PetMeds (NASDAQ PETS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 97.50%
1-800-PetMeds (NASDAQ PETS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 1/29/2018 | Ronald J Korn | Director | Sell | 5,000 | $48.38 | $241,900.00 | 68,833 |  |
| 1/22/2018 | Menderes Akdag | CEO | Sell | 10,000 | $57.00 | $570,000.00 | 470,000 | |
| 1/11/2018 | Menderes Akdag | CEO | Sell | 30,000 | $51.00 | $1,530,000.00 | 490,000 | |
| 12/15/2017 | Gian Fulgoni | Director | Sell | 20,000 | $44.38 | $887,600.00 | 55,900 | |
| 10/27/2017 | Ronald J Korn | Director | Sell | 1,000 | $35.57 | $35,570.00 | 73,833 | |
| 8/1/2017 | Robert C Schweitzer | Director | Sell | 2,500 | $49.18 | $122,950.00 | 88,834 | |
| 7/28/2017 | Ronald J Korn | Director | Sell | 5,000 | $48.18 | $240,900.00 | 67,333 | |
| 7/27/2017 | Bruce S Rosenbloom | CFO | Sell | 6,833 | $50.18 | $342,879.94 | 18,534 | |
| 7/27/2017 | Robert C Schweitzer | Director | Sell | 5,000 | $48.60 | $243,000.00 | 83,834 | |
| 5/16/2017 | Frank J Formica | Director | Sell | 5,000 | $35.32 | $176,600.00 | 46,000 | |
| 5/10/2017 | Gian Fulgoni | Director | Sell | 35,000 | $32.22 | $1,127,700.00 | 68,400 | |
| 5/8/2017 | Bruce S Rosenbloom | Insider | Sell | 9,000 | $27.00 | $243,000.00 | 25,267 | |
| 5/1/2017 | Bruce S Rosenbloom | Insider | Sell | 1,500 | $24.00 | $36,000.00 | 34,267 | |
| 12/13/2016 | Menderes Akdag | CEO | Sell | 10,000 | $23.00 | $230,000.00 | 520,000 | |
| 12/9/2016 | Bruce S Rosenbloom | Insider | Sell | 1,500 | $23.00 | $34,500.00 | 35,767 | |
| 12/7/2016 | Menderes Akdag | CEO | Sell | 3,107 | $22.75 | $70,684.25 | 532,674 | |
| 11/25/2016 | Menderes Akdag | CEO | Sell | 6,274 | $22.25 | $139,596.50 | 550,000 | |
| 11/16/2016 | Frank J Formica | Director | Sell | 10,000 | $21.75 | $217,500.00 | 51,000 | |
| 11/14/2016 | Bruce S Rosenbloom | Insider | Sell | 3,000 | $21.75 | $65,250.00 | 38,767 | |
| 11/14/2016 | Menderes Akdag | CEO | Sell | 40,000 | $21.63 | $865,200.00 | 590,000 | |
| 10/10/2016 | Bruce S Rosenbloom | Insider | Sell | 1,500 | $21.00 | $31,500.00 | 41,767 | |
| 10/10/2016 | Menderes Akdag | CEO | Sell | 10,000 | $21.00 | $210,000.00 | 600,000 | |
| 9/22/2016 | Menderes Akdag | CEO | Sell | 10,000 | $20.75 | $207,500.00 | 610,000 | |
| 8/12/2016 | Bruce S Rosenbloom | Insider | Sell | 8,000 | $20.38 | $163,040.00 | 43,267 | |
| 8/11/2016 | Robert C Schweitzer | Director | Sell | 3,000 | $20.59 | $61,770.00 | 90,334 | |
| 8/9/2016 | Robert C Schweitzer | Director | Sell | 4,500 | $20.52 | $92,340.00 | 94,834 | |
| 8/1/2016 | Ronald J Korn | Director | Sell | 4,000 | $20.76 | $83,040.00 | 75,333 | |
| 5/9/2016 | Bruce S Rosenbloom | CFO | Sell | 5,500 | $19.54 | $107,470.00 | 44,767 | |
| 3/30/2016 | Bruce S Rosenbloom | CFO | Sell | 1,500 | $18.00 | $27,000.00 | 46,267 | |
| 3/14/2016 | Bruce S Rosenbloom | CFO | Sell | 3,000 | $17.25 | $51,750.00 | 49,267 | |
| 2/22/2016 | Ronald J Korn | Director | Sell | 5,000 | $16.76 | $83,800.00 | 71,833 | |
| 1/22/2016 | Bruce S Rosenbloom | CFO | Sell | 750 | $18.50 | $13,875.00 | 50,767 | |
| 11/20/2015 | Ronald J Korn | Director | Sell | 1,000 | $17.01 | $17,010.00 | 76,833 | |
| 7/14/2015 | Bruce S Rosenbloom | CFO | Sell | 400 | $18.25 | $7,300.00 | | |
| 7/13/2015 | Bruce S Rosenbloom | CFO | Sell | 100 | $18.25 | $1,825.00 | | |
| 6/19/2015 | Bruce S Rosenbloom | CFO | Sell | 1,000 | $17.88 | $17,880.00 | | |
| 6/19/2015 | Menderes Akdag | CEO | Sell | 8,000 | $17.75 | $142,000.00 | | |
| 6/4/2015 | Menderes Akdag | CEO | Sell | 9,930 | $17.50 | $173,775.00 | | |
| 5/8/2015 | Frank J Formica | Director | Sell | 7,500 | $16.51 | $123,825.00 | | |
| 4/23/2015 | Menderes Akdag | CEO | Sell | 10,000 | $17.25 | $172,500.00 | | |
| 4/20/2015 | Menderes Akdag | CEO | Sell | 10,000 | $17.00 | $170,000.00 | | |
| 4/13/2015 | Menderes Akdag | CEO | Sell | 7,499 | $16.75 | $125,608.25 | | |
| 4/13/2015 | Ronald J Korn | Director | Sell | 2,000 | $16.75 | $33,500.00 | | |
| 4/8/2015 | Menderes Akdag | CEO | Sell | 2,501 | $16.75 | $41,891.75 | | |
| 3/30/2015 | Menderes Akdag | CEO | Sell | 10,000 | $16.50 | $165,000.00 | | |
| 3/25/2015 | Ronald J Korn | Director | Sell | 2,000 | $16.25 | $32,500.00 | | |
| 1/21/2015 | Menderes Akdag | CEO | Sell | 60,000 | $15.63 | $937,800.00 | | |
| 1/20/2015 | Bruce S Rosenbloom | CFO | Sell | 2,167 | $15.40 | $33,371.80 | | |
| 8/15/2014 | Ronald J Korn | Director | Sell | 2,000 | $14.13 | $28,260.00 | | |
| 7/22/2014 | Bruce S Rosenbloom | CFO | Sell | 1,000 | $14.13 | $14,130.00 | | |
| 7/21/2014 | Bruce S Rosenbloom | CFO | Sell | 500 | $14.00 | $7,000.00 | | |
| 6/12/2014 | Bruce S Rosenbloom | CFO | Sell | 1,500 | $13.50 | $20,250.00 | | |
| 9/13/2013 | Menderes Akdag | CEO | Sell | 10,000 | $17.00 | $170,000.00 | 618,000 | |
| 9/11/2013 | Bruce S Rosenbloom | CFO | Sell | 6,666 | $16.21 | $108,055.86 | | |
| 8/14/2013 | Ronald Korn | Director | Sell | 1,000 | $16.25 | $16,250.00 | 72,833 | |
| 8/12/2013 | Ronald Korn | Director | Sell | 1,000 | $16.18 | $16,180.00 | 73,833 | |
| 7/31/2013 | Frank J Formica | Director | Sell | 7,000 | $16.39 | $114,730.00 | | |
| 7/22/2013 | Bruce S Rosenbloom | CFO | Sell | 6,250 | $16.74 | $104,625.00 | | |
| 3/6/2013 | Ronald J Korn | Director | Sell | 2,000 | $13.50 | $27,000.00 | | |
(Data available from 1/1/2013 forward)
1-800-PetMeds (NASDAQ PETS) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | 1-800-PetMeds (PETS) vs. CVS Health (CVS) Financial Contrast
www.americanbankingnews.com - May 19 at 9:21 PM |
| Financial Review: HealthWarehouse.com (HEWA) & 1-800-PetMeds (PETS)
www.americanbankingnews.com - May 19 at 1:05 PM |
 | Amazon (AMZN) Plans to Open Sixth Fulfillment Center in Ohio (revised)
finance.yahoo.com - May 16 at 5:52 PM |
| Reviewing 1-800-PetMeds (PETS) and HealthWarehouse.com (HEWA)
www.americanbankingnews.com - May 16 at 11:33 AM |
| Reviewing 1-800-PetMeds (PETS) and CVS Health (CVS)
www.americanbankingnews.com - May 14 at 11:16 PM |
| 3 Days Left To Cash In On PetMed Express Inc (NASDAQ:PETS) Dividend, Should Investors Buy?
finance.yahoo.com - May 13 at 6:41 PM |
| 1-800-PetMeds (PETS) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 9 at 6:47 PM |
| Q1 2019 EPS Estimates for 1-800-PetMeds Raised by Northcoast Research (PETS)
www.americanbankingnews.com - May 9 at 9:43 AM |
| 1-800-PetMeds (PETS) Cut to Hold at ValuEngine
www.americanbankingnews.com - May 8 at 11:26 PM |
 | Form 8-K PETMED EXPRESS INC For: May 07
www.streetinsider.com - May 8 at 5:48 PM |
| PetMed (PETS) Q4 Earnings Top Estimates, Reorder Sales Solid
finance.yahoo.com - May 8 at 5:48 PM |
| 1-800-PetMeds (PETS) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - May 8 at 3:23 PM |
| 1-800-PetMeds (PETS) Price Target Cut to $38.00
www.americanbankingnews.com - May 8 at 2:46 PM |
| 1-800-PetMeds (PETS) Posts Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - May 7 at 11:30 AM |
| 1-800-PetMeds (PETS) Declares Quarterly Dividend of $0.25
www.americanbankingnews.com - May 7 at 9:12 AM |
 | PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly ...
www.nasdaq.com - May 7 at 8:13 AM |
| PetMed Express, Inc. to Host Earnings Call
finance.yahoo.com - May 7 at 8:13 AM |
| PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share
finance.yahoo.com - May 7 at 8:13 AM |
| Head-To-Head Analysis: Express Scripts (ESRX) versus 1-800-PetMeds (PETS)
www.americanbankingnews.com - May 6 at 3:20 PM |
| Comparing 1-800-PetMeds (PETS) & HealthWarehouse.com (HEWA)
www.americanbankingnews.com - May 5 at 10:10 AM |
| ValuEngine Upgrades 1-800-PetMeds (PETS) to "Buy"
www.americanbankingnews.com - May 2 at 10:54 PM |
| 1-800-PetMeds (PETS) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - May 1 at 1:26 AM |
| PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 7, 2018
finance.yahoo.com - April 30 at 8:14 AM |
| 1-800-PetMeds (PETS) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - April 30 at 2:56 AM |
| PetMed Express (PETS) is Oversold: Can It Recover?
finance.yahoo.com - April 26 at 5:22 PM |
| Brokerages Anticipate 1-800-PetMeds (PETS) Will Post Quarterly Sales of $67.55 Million
www.americanbankingnews.com - April 26 at 4:34 AM |
| PetMed Express Inc (NASDAQ:PETS) Investors Are Paying Above The Intrinsic Value
finance.yahoo.com - April 25 at 8:11 AM |
| 1-800-PetMeds (PETS) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 25 at 12:24 AM |
| Brokerages Expect 1-800-PetMeds (PETS) to Announce $0.44 Earnings Per Share
www.americanbankingnews.com - April 24 at 8:08 AM |
| The Zacks Analyst Blog Highlights: Etsy, eBay, Amazon and PetMed Express
finance.yahoo.com - April 20 at 5:28 PM |
| Contrasting 1-800-PetMeds (PETS) & Express Scripts (ESRX)
www.americanbankingnews.com - April 18 at 5:15 PM |
| 1-800-PetMeds (PETS) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 18 at 9:51 AM |
| Is PetMed Express Inc (NASDAQ:PETS) A Smart Choice For Dividend Investors?
finance.yahoo.com - April 17 at 8:20 AM |
| Financial Review: 1-800-PetMeds (PETS) & Express Scripts (ESRX)
www.americanbankingnews.com - April 14 at 5:11 PM |
| 1-800-PetMeds (PETS) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - April 13 at 11:10 PM |
| Comparing 1-800-PetMeds (PETS) and Express Scripts (ESRX)
www.americanbankingnews.com - April 13 at 7:19 PM |
| 1-800-PetMeds (PETS) Expected to Announce Quarterly Sales of $67.84 Million
www.americanbankingnews.com - April 9 at 3:44 AM |
| Walgreens Boots Alliance (WBA) versus 1-800-PetMeds (PETS) Critical Survey
www.americanbankingnews.com - April 8 at 11:23 AM |
| 1-800-PetMeds (PETS) Downgraded by ValuEngine
www.americanbankingnews.com - April 8 at 11:17 AM |
| 1-800-PetMeds (PETS) Expected to Announce Earnings of $0.44 Per Share
www.americanbankingnews.com - April 7 at 8:08 AM |
| 1-800-PetMeds (PETS) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 6 at 1:36 AM |
| 1-800-PetMeds (PETS) and Walgreens Boots Alliance (WBA) Critical Analysis
www.americanbankingnews.com - April 4 at 9:21 PM |
| 1-800-PetMeds (PETS) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 10:33 AM |
| 1-800-PetMeds (PETS) vs. Walgreens Boots Alliance (WBA) Financial Survey
www.americanbankingnews.com - April 2 at 7:16 PM |
| Should You Buy PetMed Express Inc (NASDAQ:PETS)?
finance.yahoo.com - March 30 at 5:38 PM |
| Amazon Teams Up With Monoprix, Bolsters Presence in Europe
finance.yahoo.com - March 27 at 5:20 PM |
| Petmed Express (PETS) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - March 25 at 11:21 AM |
| $67.84 Million in Sales Expected for Petmed Express Inc (PETS) This Quarter
www.americanbankingnews.com - March 23 at 9:36 AM |
| Petmed Express Inc (PETS) Expected to Post Earnings of $0.44 Per Share
www.americanbankingnews.com - March 21 at 12:36 PM |
 | Top Ranked Growth Stocks to Buy for March 19th
www.zacks.com - March 20 at 5:23 PM |
1-800-PetMeds (NASDAQ:PETS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
1-800-PetMeds (NASDAQ:PETS) Income Statement, Balance Sheet and Cash Flow Statement
1-800-PetMeds (NASDAQ PETS) Stock Chart for Tuesday, May, 22, 2018
Loading chart…
